Non-Hodgkin's lymphoma presenting as multiple bone lesions and hypercalcemia. 2006

Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

We report a rare case of a patient with non-Hodgkin's lymphoma who developed multiple bone lesions and hypercalcemia. A 50-year-old woman complained of drowsiness and multiple bone pain on admission. Radiographic examination revealed multiple bone fractures and osteolytic lesions. She was diagnosed with diffuse large B cell lymphoma by biopsy of an inguinal lymph node. Elevation of parathyroid hormone-related protein (PTHrP) and hypercalcemia were confirmed pretreatment, and those serum levels decreased during chemotherapy for lymphoma. However, the disease was resistant to chemotherapy combined with rituximab. These findings suggest that hypercalcemia is associated with PTHrP and the prognosis of patients with bone lymphoma in advanced stage is poor, although it is thought to be a relatively favorable prognosis in localized primary lymphoma of bone.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008228 Lymphoma, Non-Hodgkin Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. Non-Hodgkin Lymphoma,Diffuse Mixed Small and Large Cell Lymphoma,Diffuse Mixed-Cell Lymphoma,Diffuse Small Cleaved-Cell Lymphoma,Diffuse Undifferentiated Lymphoma,Lymphatic Sarcoma,Lymphoma, Atypical Diffuse Small Lymphoid,Lymphoma, Diffuse,Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic,Lymphoma, High-Grade,Lymphoma, Intermediate-Grade,Lymphoma, Low-Grade,Lymphoma, Mixed,Lymphoma, Mixed Cell, Diffuse,Lymphoma, Mixed Lymphocytic-Histiocytic,Lymphoma, Mixed Small and Large Cell, Diffuse,Lymphoma, Mixed-Cell,Lymphoma, Mixed-Cell, Diffuse,Lymphoma, Non-Hodgkin's,Lymphoma, Non-Hodgkin, Familial,Lymphoma, Non-Hodgkins,Lymphoma, Nonhodgkin's,Lymphoma, Nonhodgkins,Lymphoma, Pleomorphic,Lymphoma, Small Cleaved Cell, Diffuse,Lymphoma, Small Cleaved-Cell, Diffuse,Lymphoma, Small Non-Cleaved-Cell,Lymphoma, Small Noncleaved-Cell,Lymphoma, Small and Large Cleaved-Cell, Diffuse,Lymphoma, Undifferentiated,Lymphoma, Undifferentiated, Diffuse,Lymphosarcoma,Mixed Small and Large Cell Lymphoma, Diffuse,Mixed-Cell Lymphoma,Mixed-Cell Lymphoma, Diffuse,Non-Hodgkin's Lymphoma,Reticulosarcoma,Reticulum Cell Sarcoma,Reticulum-Cell Sarcoma,Sarcoma, Lymphatic,Sarcoma, Reticulum-Cell,Small Cleaved-Cell Lymphoma, Diffuse,Small Non-Cleaved-Cell Lymphoma,Small Noncleaved-Cell Lymphoma,Undifferentiated Lymphoma,Diffuse Lymphoma,Diffuse Lymphomas,Diffuse Mixed Cell Lymphoma,Diffuse Mixed-Cell Lymphomas,Diffuse Small Cleaved Cell Lymphoma,Diffuse Undifferentiated Lymphomas,High-Grade Lymphoma,High-Grade Lymphomas,Intermediate-Grade Lymphoma,Intermediate-Grade Lymphomas,Low-Grade Lymphoma,Low-Grade Lymphomas,Lymphatic Sarcomas,Lymphocytic-Histiocytic Lymphoma, Mixed,Lymphocytic-Histiocytic Lymphomas, Mixed,Lymphoma, Diffuse Mixed-Cell,Lymphoma, Diffuse Undifferentiated,Lymphoma, High Grade,Lymphoma, Intermediate Grade,Lymphoma, Low Grade,Lymphoma, Mixed Cell,Lymphoma, Mixed Lymphocytic Histiocytic,Lymphoma, Non Hodgkin,Lymphoma, Non Hodgkin's,Lymphoma, Non Hodgkins,Lymphoma, Nonhodgkin,Lymphoma, Small Non Cleaved Cell,Lymphoma, Small Noncleaved Cell,Lymphosarcomas,Mixed Cell Lymphoma,Mixed Cell Lymphoma, Diffuse,Mixed Lymphocytic-Histiocytic Lymphoma,Mixed Lymphocytic-Histiocytic Lymphomas,Mixed Lymphoma,Mixed Lymphomas,Mixed-Cell Lymphomas,Non Hodgkin Lymphoma,Non Hodgkin's Lymphoma,Non-Cleaved-Cell Lymphoma, Small,Non-Hodgkins Lymphoma,Noncleaved-Cell Lymphoma, Small,Nonhodgkin's Lymphoma,Nonhodgkins Lymphoma,Pleomorphic Lymphoma,Pleomorphic Lymphomas,Reticulosarcomas,Reticulum Cell Sarcomas,Reticulum-Cell Sarcomas,Sarcoma, Reticulum Cell,Small Cleaved Cell Lymphoma, Diffuse,Small Non Cleaved Cell Lymphoma,Small Non-Cleaved-Cell Lymphomas,Small Noncleaved Cell Lymphoma,Small Noncleaved-Cell Lymphomas,Undifferentiated Lymphoma, Diffuse,Undifferentiated Lymphomas
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010014 Osteolysis Dissolution of bone that particularly involves the removal or loss of calcium. Osteolyses
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006934 Hypercalcemia Abnormally high level of calcium in the blood. Milk-Alkali Syndrome,Hypercalcemias,Milk Alkali Syndrome,Syndrome, Milk-Alkali
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody

Related Publications

Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
January 2021, European journal of case reports in internal medicine,
Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
July 1984, Revista medica de Chile,
Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
September 1993, The European respiratory journal,
Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
January 1984, The New England journal of medicine,
Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
July 1975, Clinical radiology,
Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
February 1995, British journal of rheumatology,
Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
September 1994, British journal of rheumatology,
Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
January 1994, British journal of rheumatology,
Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
January 2012, Journal of the Massachusetts Dental Society,
Hirotaka Takasaki, and Heiwa Kanamori, and Maki Takabayashi, and Satoshi Yamaji, and Hideyuki Koharazawa, and Jun Taguchi, and Katsumichi Fujimaki, and Yoshiaki Ishigatsubo
January 2006, Boletin de la Asociacion Medica de Puerto Rico,
Copied contents to your clipboard!